CA2023018A1 - Derives de 2-oxo-3,8-diazaspiro/4,5/decane, composes pharmaceutiques les contenant et procede de preparation - Google Patents

Derives de 2-oxo-3,8-diazaspiro/4,5/decane, composes pharmaceutiques les contenant et procede de preparation

Info

Publication number
CA2023018A1
CA2023018A1 CA2023018A CA2023018A CA2023018A1 CA 2023018 A1 CA2023018 A1 CA 2023018A1 CA 2023018 A CA2023018 A CA 2023018A CA 2023018 A CA2023018 A CA 2023018A CA 2023018 A1 CA2023018 A1 CA 2023018A1
Authority
CA
Canada
Prior art keywords
group
4alkyl
same
diazaspiro
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2023018A
Other languages
English (en)
Other versions
CA2023018C (fr
Inventor
Edit Toth
Jozsef Torley
Sandor Gorog
Laszlo Szporny
Bela Kiss
Eva Palosi
Dora Groo
Istvan Laszlovszky
Erzsebet Lapis
Ferenc Auth
Laszlo Gaal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of CA2023018A1 publication Critical patent/CA2023018A1/fr
Application granted granted Critical
Publication of CA2023018C publication Critical patent/CA2023018C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
CA002023018A 1989-08-10 1990-08-09 Derives de 2-oxo-3,8-diazaspiro/4,5/decane, composes pharmaceutiques les contenant et procede de preparation Expired - Fee Related CA2023018C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU894094A HU204276B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-4-methylen-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
HU4094/89 1989-08-10

Publications (2)

Publication Number Publication Date
CA2023018A1 true CA2023018A1 (fr) 1991-02-11
CA2023018C CA2023018C (fr) 1995-11-28

Family

ID=10966866

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002023015A Abandoned CA2023015A1 (fr) 1989-08-10 1990-08-09 Dejrives de 4-methylene-2-oxo-8-azaspiro/4,5/decane, composes pharmaceutiques les contenant et procede de preparation
CA002023018A Expired - Fee Related CA2023018C (fr) 1989-08-10 1990-08-09 Derives de 2-oxo-3,8-diazaspiro/4,5/decane, composes pharmaceutiques les contenant et procede de preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002023015A Abandoned CA2023015A1 (fr) 1989-08-10 1990-08-09 Dejrives de 4-methylene-2-oxo-8-azaspiro/4,5/decane, composes pharmaceutiques les contenant et procede de preparation

Country Status (26)

Country Link
US (2) US5132309A (fr)
EP (2) EP0413516B1 (fr)
JP (2) JPH0381277A (fr)
KR (2) KR940002826B1 (fr)
CN (1) CN1025031C (fr)
AT (2) ATE113951T1 (fr)
AU (2) AU621238B2 (fr)
CA (2) CA2023015A1 (fr)
DD (2) DD299431A5 (fr)
DE (2) DE69014008T2 (fr)
DK (1) DK0413516T3 (fr)
ES (2) ES2052179T3 (fr)
FI (1) FI93456C (fr)
HK (1) HK118295A (fr)
HU (2) HU204276B (fr)
IE (1) IE902885A1 (fr)
IL (2) IL95324A (fr)
IN (1) IN170979B (fr)
IS (1) IS3612A7 (fr)
MY (1) MY107240A (fr)
NO (1) NO903511L (fr)
NZ (2) NZ234843A (fr)
PL (2) PL163899B1 (fr)
SG (1) SG59864G (fr)
YU (2) YU150489A (fr)
ZA (3) ZA906300B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985437A (en) * 1986-12-17 1991-01-15 Glaxo Group Limited Medicaments
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
EP0492020A1 (fr) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Utilisation de certains esters de la hexahydro-8-hydroxy-2,6-méthano-2H-quinolizine-3(4H)-one et des composés apparentés pour le traitement des maladies cognitives
GB9206989D0 (en) * 1992-03-31 1992-05-13 Glaxo Group Ltd Chemical compounds
US5756743A (en) * 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!
US6100256A (en) * 1996-12-02 2000-08-08 Merck Sharp & Dohme Ltd. Use of NK-1 receptors antagonists for treating schizophrenic disorders
US6974825B1 (en) 1996-12-20 2005-12-13 Astrazeneca Canada Inc. Compounds with analgesic effect
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
SE9904675D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0101771D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101773D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101769D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101770D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
KR20030087248A (ko) * 2002-05-08 2003-11-14 (주)씨엔아이 온라인을 통한 상거래 기초항목의 설정기능을 갖는 상거래관리장치
US8921555B2 (en) * 2009-06-16 2014-12-30 Merck Sharp & Dohme Corp. Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
GB201416352D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127065C (fr) * 1964-04-22
CH601304A5 (fr) * 1974-02-12 1978-07-14 Buskine Sa
BE790675A (fr) * 1971-10-29 1973-04-27 Science Union & Cie Nouveaux derives de l'oxa-1 diaza-3,8 spiro (4,5) decane
FR2615515B1 (fr) * 1987-05-22 1989-06-30 Adir Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
HU204530B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NO903511D0 (no) 1990-08-09
KR910004630A (ko) 1991-03-29
DD299431A5 (de) 1992-04-16
IL95324A0 (en) 1991-06-30
KR940000830B1 (ko) 1994-02-02
EP0413516A3 (en) 1991-11-27
EP0412821B1 (fr) 1994-11-09
DD299428A5 (de) 1992-04-16
DE69008275D1 (de) 1994-05-26
DK0413516T3 (da) 1994-05-24
HUT55785A (en) 1991-06-28
AU621771B2 (en) 1992-03-19
HU206677B (en) 1992-12-28
NZ234843A (en) 1992-03-26
AU6080490A (en) 1991-02-14
JPH0381277A (ja) 1991-04-05
PL291648A1 (en) 1992-06-01
PL286443A1 (en) 1992-01-13
HK118295A (en) 1995-07-28
DE69014008D1 (de) 1994-12-15
HU204276B (en) 1991-12-30
YU154090A (sh) 1992-12-21
NO903511L (no) 1991-02-11
IE902885A1 (en) 1991-02-27
YU150489A (sh) 1992-12-21
ZA906304B (en) 1991-06-26
AU6080390A (en) 1991-02-14
ATE104671T1 (de) 1994-05-15
IL95325A0 (en) 1991-06-30
HUT59375A (en) 1992-05-28
IL95324A (en) 1994-02-27
NZ234846A (en) 1992-03-26
DE69008275T2 (de) 1994-08-04
ES2052179T3 (es) 1994-07-01
EP0412821A2 (fr) 1991-02-13
HU903233D0 (en) 1990-10-28
MY107240A (en) 1995-10-31
CN1025031C (zh) 1994-06-15
IN170979B (fr) 1992-06-27
ES2063923T3 (es) 1995-01-16
DE69014008T2 (de) 1995-03-23
FI93456B (fi) 1994-12-30
FI903974A0 (fi) 1990-08-10
CN1049349A (zh) 1991-02-20
KR940002826B1 (ko) 1994-04-04
PL163899B1 (pl) 1994-05-31
SG59864G (en) 1995-09-01
ZA906300B (en) 1991-05-29
IL95325A (en) 1994-06-24
IS3612A7 (is) 1991-02-11
US5132303A (en) 1992-07-21
AU621238B2 (en) 1992-03-05
JPH0383985A (ja) 1991-04-09
US5132309A (en) 1992-07-21
EP0413516B1 (fr) 1994-04-20
EP0413516A2 (fr) 1991-02-20
EP0412821A3 (en) 1991-11-27
CA2023018C (fr) 1995-11-28
ZA906299B (en) 1991-06-26
ATE113951T1 (de) 1994-11-15
FI93456C (fi) 1995-04-10
KR910004631A (ko) 1991-03-29
PL164662B1 (pl) 1994-09-30
CA2023015A1 (fr) 1991-02-11

Similar Documents

Publication Publication Date Title
CA2023018A1 (fr) Derives de 2-oxo-3,8-diazaspiro/4,5/decane, composes pharmaceutiques les contenant et procede de preparation
GR3018387T3 (en) Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them.
ES8706670A1 (es) Un procedimiento para preparar 1,4-dihidropiridinas
ES8602033A1 (es) Un procedimiento para preparar derivados de adenosina.
KR100271416B1 (en) Carbamate derivatives of 4-amino-3-isoxazolidinones,3-amino-1-hydroxypyrrolidin-2-ones and1-amino-1-cyclopropanecarboxylic acid analogs, aprocess for their preparation and a pharmaceuticalcomposition comprising the same
RU94046141A (ru) Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция
HUT53354A (en) Process for producing substituted 2-amino-1,2,3,4-tetrahydronaphthalene and 3-aminochromane derivatives
AU2522692A (en) Imidazol-1-yl methyl pyridine derivatives, processes for their production and their use as pharmaceuticals
AU7216087A (en) Benzhydrylpiperazine derivatives, pharmaceutical compositions containing them and process for preparing same
ES2009689A6 (es) Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima.
NZ228182A (en) Substituted 4,5,6,7-tetrahydroisothiazolo(4,5-c) pyridine derivatives and pharmaceutical compositions; methods for preparation
IE873212L (en) Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor
NZ233728A (en) Amino acid compounds and pharmaceutical compositions thereof
ES8101646A1 (es) Un procedimiento para producir un compuesto opticamente ac- tivo
MY107125A (en) Novel 2-oxo-1-oxa-8-azaspiro[4,5]decane derivatives, pharmaceutical compositions containing them and process for preparing same.
ES8704463A1 (es) Procedimiento para preparar 2-(n-alquinil-n-fenilamino)-imidazolinas
ATE147075T1 (de) Purinverbindungen, verfahren zu ihrer herstellung, pharmazeutische präparate und zwischenverbindungen
DE3378980D1 (en) Benzazepine derivatives, process for their preparation and their use as pharmaceutical compounds
ES8401062A1 (es) Procedimiento para la preparacion de nuevas 1-furil-3,4-dihidroisoquinoleinas.
ATE36154T1 (de) 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
EP0424528A4 (en) Phenylalkanoylamine derivatives, process for their preparation, and their uses

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed